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Abstract 40 
An active case detection approach with PCR diagnosis was used in the Ho District of the 41 
Volta Region that identified individuals with active cutaneous leishmaniasis. Three isolates 42 
were successfully cultured and DNA sequences from these were analysed (ribosomal 43 
RNA ITS1; RPL23a intergenic; RNA polymerase II large subunit), showing them to be 44 
Leishmania, identical to each other but different to all other known Leishmania species. 45 
Phylogenetic analysis showed the parasites to be new members of the Leishmania enriettii 46 
complex, which is emerging as a possible new subgenus of Leishmania parasites 47 
containing human pathogens. 48 
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Cutaneous leishmaniasis (CL) is a significant emerging disease in the Volta Region 53 
of Ghana (Kweku et al., 2011) and has become sufficiently common to acquire a local 54 
name, “agbamekanu”, with estimates of high prevalence in some communities. Reported 55 
infections have occurred mainly in the Ho District, a moist semi-deciduous forest zone with 56 
villages dotted around the district capital and an estimated population of 235,000 (Ghana 57 
Statistical Service, 2002 Population and Housing Census). From clinical signs, 8,533 58 
cases were recorded in Ho District in 2002 and 2003, which represents ~3-4% of the 59 
population, and in surveys of schoolchildren prevalence of leishmanial-like lesions ranged 60 
from 12.2 to 32.3 % (Kweku et al., 2011). However, the number of cases with 61 
parasitologically confirmed diagnoses is very small (Fryauff et al., 2006; Villinski et al., 62 
2007), and prior to the current study parasites causing CL in Ghana had never been 63 
isolated into culture. The identity of the species responsible remain uncertain, one PCR-64 
confirmed case from a biopsy was identified as L. major by ribosomal RNA ITS1 65 
sequencing (Fryauff et al., 2006), but in a second study conducted in the same area 66 
further biopsies found no match to any known Leishmania species (Villinkski et al., 2007). 67 
Regarding transmission, leishmaniasis is a vector-borne disease usually transmitted by 68 
sand flies but the majority caught to date in Ghana have been various Sergentomyia 69 
species, which are not generally regarded as likely vectors of human leishmaniasis 70 
(Ready, 2013). However, low numbers of the possible vectors Phlebotomus rodhaini and 71 
P. duboscqi were found (Fryauff et al., 2006). It has been recently reported that L. tropica 72 
DNA was found in Sergentomyia hamoni and S. ingrami, and L. major DNA in S. ingrami, 73 
in flies collected from the endemic region (Nzelu et al., 2014). However, the finding of 74 
parasite DNA by itself does not prove vector status, as blood meal infections can persist in 75 
non-vectors for some days but will not result in established transmissible infections 76 
(Ready, 2013). The current study was undertaken to isolate and characterize parasites 77 
causing CL in Ghana. Cultures were established for the first time, and here we present 78 
evidence that these represent a new species of Leishmania, which is related to several 79 
other species grouped within the Leishmania enriettii complex. These parasites are the 80 
first new human-infective Leishmania species to be isolated in Africa for over 40 years. 81 
Fifteen villages in Ho District with previous records of suspected or reported cases 82 
of CL were initially visited, and of these five with recent cases were followed up: Matse-83 
Lotus, Sokode-Gbogame, Dodome-Doglome, Dodome-Awiausu, and Lume-Atsyame. The 84 
study was assessed by and approved by the University of Ghana Medical School Ethical 85 
and Protocol Review Board, Protocol Identification Number MS-Et/M.6.1 – P.3/2006-07 86 
and the Noguchi Memorial Institute for Medical Research Institutional Review Board, CPN 87 
062/11-12. The purpose of the study and the procedures to be followed were explained 88 
and written informed consent was obtained from all participants or their legal guardians 89 
prior to any intervention. A total of 68 people with suspected CL were seen, of these 44 90 
were recruited into the study and 41 subsequently confirmed as infected with Leishmania, 91 
38 by PCR from dermal scrapings and 3 cases by successful culture and DNA sequence 92 
analysis (further details of sampling and other methods in Supplementary Data S1). 93 
Typical households included 10 to 14 inhabitants, and usually 1-2 people per household 94 
had healed lesions on the body suggestive of past CL. Two sets of PCR primers were 95 
used for diagnosis: Mincr2 and Mincr3 are derived from the conserved region of 96 
Leishmania species minicircle DNA of the parasite kinetoplast, generating a product of 120 97 
bp (Degrave et al., 1994; da Silva et al., 2004); R221 and R332 are Leishmania-specific 98 
and amplify a region of the 18S rRNA gene, generating a product of 603 bp (van Eys et al., 99 
1992; Meredith et al., 1993). The Mincr2/Mincr3 primer pair demonstrated better efficacy, 100 
amplifying 38 out of the 41 dermal scraping samples taken (93 %; Fig. 1A, Supplementary 101 
Fig. S1A), with the R221/R332 pair amplifying 27 out of the 41 samples (66 %; Fig. 1B, 102 
Supplementary Fig. S1B). All samples that were positive with R221/R332 were also 103 
positive with Mincr2/Mincr3, no additional positive cases were discovered with R221/R332. 104 
Thus the R221/R332 primers detected Leishmania in fewer samples, which is consistent 105 
with the lower copy number of their targets at about 160 copies per genome (van Eys et 106 
al., 1992), compared to ~10,000 copy number of the minicr1/minicr2 targets (Degrave et 107 
al., 1994). The 3 negative samples from dermal scrapings are either true negative non-108 
leishmanial skin lesions that can arise from a number of other causes, or are Leishmania 109 
infections below the level of detection. There was no evidence of other differential 110 
diagnoses from Buruli ulcer, yaws or cutaneous fungal infections amongst the participants. 111 
Use of dermal scrapings for diagnosis of Leishmania is a minimally invasive sampling 112 
method for CL, and another useful aspect of this study was the ability of the primers to 113 
detect Leishmania from the lesion material on FTA cards, without the need for separate 114 
isolation of DNA from clinical samples.  115 
Three lesion aspirate samples from separate individuals were used to establish 116 
promastigote cultures. Sloppy Evans semi-solid medium was prepared by mixing 350 ml of 117 
Locke’s solution (9 g NaCl, 0.42 g KCl, 0.4 g CaCl, 0.2 g NaHCO3, 1 g Glucose and dH20 118 
to 1 litre) with 1.3 g Agar No 1, 2 g bacteriological peptone, and 0.2 g Beef extract (Bovril), 119 
which was autoclaved, after which 50 ml defibrinated sterile rabbit blood was added, mixed 120 
and 2 ml aliquots dispensed into sterile bijou tubes. Lesion aspirates were transferred into 121 
2ml volumes of Sloppy Evans, incubated at 26 ºC and checked every 48 hours for up to a 122 
month by phase contrast microscopy. Upon observing promastigotes, aliquots were 123 
transferred into liquid culture medium comprised of Medium 199 (Life Technologies 12350-124 
039) supplemented with 20 % (v/v) fetal bovine serum, BME vitamins (Sigma B6891) and 125 
25 µg/ml gentamicin sulphate. Cultures were expanded and sub-passaged as required and 126 
promastigotes cryopreserved in 7.5 % glycerol at -80 ºC and liquid nitrogen. The WHO 127 
codes for these isolates are MHOM/GH/2012/GH5;LV757, MHOM/GH/2012/GH10;LV758 128 
and MHOM/GH/2012/GH11;LV759, hereafter referred to as GH5, GH10 and GH11, 129 
respectively. Amplification of the ITS1 sequence from each isolate was performed, and the 130 
resulting sequences were found to be very similar or identical to each other and to the 131 
sequence previously reported by Villinski et al. (2007) derived from CL lesion biopsies, 132 
showing 99.2-99.6% identity (Supplementary Fig. S2). These sequences are more similar 133 
to each other than to any other known Leishmania sequence, and the degree of similarity 134 
is what would be expected for ITS1 sequences from different isolates of the same species. 135 
Infection in confirmed cases was predominantly in younger age groups (~58% were 136 
up to 10 years old), although the age range included from infants to adults above fifty 137 
years (Supplementary Table S2). The majority of these were recent infections with open 138 
sores in which the observed lesions were either crusted or ulcerated (Fig. 2). No nodular 139 
or papular forms were observed. The lesions of the majority of participants were circular, 140 
except for one person who had both circular and oval lesions. Their appearance was 141 
relatively uniform, perhaps indicating the presence of a single species responsible for CL. On 142 
the other hand, there is often wide variation in the appearance of lesions even with a 143 
single species (Reithinger et al., 2007). More work is required to see if any pattern or 144 
significant variation of lesion form emerges in Ghana. The number of lesions per person 145 
ranged from 1 to 3, and no multiple diffused lesions were observed on any of the 146 
participants. In all, a total of 51 lesions were found on confirmed cases, of these 33 147 
individuals had single lesions, 6 had two lesions and 2 had three lesions. The average size 148 
in diameter and reported age of the lesions (according to the participants) were 11.1 mm 149 
and 3.9 weeks, respectively. The sites of the lesions were classified into five regions and 150 
approximately half (53%), were located on the head (Supplementary Table S3). This could 151 
simply mean that the vector preferred uncovered parts of the body, consistent with the fact 152 
that the vector if active at night will bite the exposed head parts, since people will typically 153 
cover the body but not the head when asleep, or be due to some behavioral property of 154 
the vector. There were no reports of severe clinical symptoms accompanying the lesions, 155 
there were a few reports of low grade fever, and slight pain and discomfort associated with 156 
the ulcers. The recruitment of participants was not evenly distributed through time, with the 157 
number of cases detected increasing from July, peaking in September and declining to 158 
November (Supplementary Fig. S3). This peak in recruitment is approximately three 159 
months after the peak in rainfall in June, the rainy season running from May to November, 160 
which could have contributed to increased transmission by elevating vector numbers. This 161 
is similar to findings in Afghanistan, where a rise in numbers of CL in various age groups 162 
from August to November and then a decline in December were reported (Faulde et al., 163 
2007). This pattern is also consistent with the typical evolution of CL, where a lesion will 164 
develop over a period of 2-3 months before beginning to heal and form scar tissue. There 165 
were old scars in some individuals, which were dappled, somewhat depressed and de-166 
pigmented, suggestive of earlier CL in the communities (Okwori et al., 2001; Mendonca et 167 
al., 2004).  168 
DNA was isolated from the three isolates established in culture. Initial identification 169 
of these was performed using a PCR-RFLP test we have developed that amplifies across 170 
a single copy intergenic region of approximately 1.5 kb between the RPLS7A and RPS7B 171 
genes (L. major chromosome 1) using primers AM1/AM2. This target has been found to 172 
give species-specific banding patterns in all of a wide range of Leishmania species 173 
examined to date.  A single product was generated from each of the three isolates, GH5, 174 
GH10 and GH11, which when digested with MspI generated identical bands in each case 175 
that were completely different to those found with reference strains (Fig. 1C). In addition to 176 
the data shown, the banding pattern of the Ghanaian isolates was different to that seen in 177 
a wide range of additional reference strains examined, including L. infantum, L. donovani, 178 
L. amazonensis, L. mexicana, L. braziliensis and L. guyanensis. These results are 179 
consistent with the Ghanaian parasites representing a new species. To investigate this 180 
further, PCR was performed on GH5, GH10 and GH11 DNA using the BN1/BN2 primers 181 
that amplify a single copy intergenic region of 450-500bp between two RPL23a genes (L. 182 
major chromosome 6), followed by sequencing, as used previously for phylogenetic 183 
analysis (Dougall et al., 2011). Each isolate generated a 468bp product of identical 184 
sequence. Analysis of these sequences and comparison with the homologous sequences 185 
from a range of other Leishmania species in a maximum likelihood (ML) tree is shown in 186 
Figure 3A. The three established subgenera, Leishmania (Leishmania), Leishmania 187 
(Sauroleishmania) and Leishmania (Viannia) were all supported with high bootstrap 188 
values, as was the L. enriettii complex and the paraleishmania. The Ghanaian parasites 189 
clustered within the L. enriettii complex, which includes L. enriettii itself (Lainson, 1997), L. 190 
martiniquensis (Desbois et al., 2014), a new as yet un-named species from Australia (AM-191 
2004) (Rose et al., 2004) and "L. siamensis" (Bualert et al., 2012). It should be noted that 192 
"L. siamensis" has not been formally described, despite appearing in the literature several 193 
times, and is therefore currently a nomen nudum, hence the name is used in quotation 194 
marks. Further, although the majority of "L. siamensis" appear to be L. martiniquensis, the 195 
isolate analysed here is the PCM2 Trang strain, which is not L. martiniquensis (Pothirat et 196 
al., 2014). Within the L. enriettii complex the most closely related species to the Ghanaian 197 
parasites is "L. siamensis PCM2 Trang" (98.29% identity, 460/468 nucleotides) followed by 198 
L. enriettii (90.26% identity) according to the RPL23a tree. Finally we also generated 199 
sequences for the RNA polymerase II large subunit gene (RNA PolII; L. major 200 
chromosome 31), a conserved single copy housekeeping gene that has also been 201 
previously used to construct Leishmania phylogenies (Croan et al., 1997; Noyes et al., 202 
2002; Yurchenko et al., 2006; Dougall et al., 2011; Pothirat et al., 2014). The sequences 203 
from the three isolates were again identical to each other and the resulting ML tree is 204 
shown in Figure 3B. This tree is topologically very similar to Figure 3A, the main groups 205 
were well supported, and again the Ghanaian isolates clustered within the L. enriettii 206 
complex. In this tree the most closely related species to the Ghanaian parasites appears 207 
different and to be L. enriettii (98.42% identity, 1181/1200 nucleotides) followed by "L. 208 
siamensis" (98.08% identity), however, there is relatively low bootstrap support (48%) on 209 
the branch including L. enriettii. Thus the sequences derived for both the RPL23a 210 
intergenic and RNA Pol II sequences were identical between the three isolates, but 211 
different from all the Leishmania species examined, which includes all the major human 212 
pathogens. 213 
The phylogenetic analysis showed the Ghanaian parasites to be members of the L. 214 
enriettii complex, a possible new subgenus of Leishmania parasites. To date, the evidence 215 
for a new subgenus is by inference from phylogenetic analyses such as those presented 216 
here and previously (Dougall et al., 2011; Pothirat et al., 2014). Members of the L. enriettii 217 
complex are clearly not placed within any of the existing subgenera, L. (Leishmania), L. 218 
(Viannia) or L. (Sauroleishmania), and the root of the branch leading to the L. enriettii 219 
complex is deep and of similar separation to the other subgenera. However, many 220 
important details of the biology of these parasites that would be required to make a precise 221 
definition of the possible subgenus are still unknown, so until there is progress in that 222 
regard this proposition remains to be decided. For example, there is little to no current 223 
information on natural reservoir hosts for any species in the L. enriettii complex. In both ML 224 
trees the location of the Ghanaian isolates within the L. enriettii complex was supported by 225 
high bootstrap values. The most closely related species are L. enriettii and "L. siamensis", 226 
but the extent of the sequence variation clearly discriminates these species from each 227 
other and the Ghanaian parasites. Taking the RNA PolII gene as an example, the extent of 228 
sequence identity between the Ghanaian parasites and "L. siamensis" is 98.08%, which is 229 
less than between L. major and L. tropica (98.75%), or L. braziliensis and L. panamensis 230 
(98.92%), which most authorities would regard as valid species. Although more work 231 
needs to be done and genetic divergence is not the only consideration, the data currently 232 
available supports the notion that the Ghanaian parasites are a distinct species of 233 
Leishmania.  L. enriettii is not a human pathogen, having only been isolated from domestic 234 
guinea pigs in southern Brazil (Lainson, 1997), whereas "L. siamensis" is a human 235 
pathogen (Bualert et al., 2012).  Of the other two known members of the L. enriettii 236 
complex, the un-named species from Australia is also not a human pathogen, having only 237 
been found in kangaroos and other macropods (Rose et al., 2004; Dougall et al., 2009), 238 
whereas L. martiniquensis causes human disease manifesting as both CL and visceral 239 
leishmaniasis (Desbois et al., 2014; Pothirat et al., 2014; Liautaud et al., 2014). Allied to 240 
this, the L. enriettii complex consistently appears as the most basal clade within the 241 
Leishmania, excluding paraleishmania, an informal grouping that requires re-classification 242 
but not regarded as Leishmania species sensu stricto (Cupolillo et al., 2000). Thus what 243 
emerges is an early diverging group of parasites that has become geographically widely 244 
dispersed, distributed among a wide diversity of hosts, but including some species with the 245 
potential to cause human disease. One of the most intriguing aspects of the L. enriettii 246 
complex is the identity of the vectors responsible for transmission, which have not been 247 
established with certainty for any species. However, recent evidence indicates that day-248 
biting midges are responsible for transmitting leishmaniasis to kangaroos in Australia 249 
(Dougall et al., 2011). Therefore, it is possible that midges may be involved in transmission 250 
of the Ghanaian parasites, despite the presence of candidate sand flies. 251 
Cumulatively these data demonstrate that the GH5, GH10 and GH11 isolates are 252 
representative of a new human-infective Leishmania species in Ghana. Given the previous 253 
report of one case of L. major infection (Fryauff et al., 2006) we cannot exclude the 254 
possibility that other Leishmania species may be present in this endemic focus, and 255 
identification of further human isolates is required to assess this possibility. However, the 256 
evidence for the presence of other species is currently not strong, and typically only one 257 
species is found in a particular landscape and ecological niche (Ready, 2013), although 258 
multiple species may be geographically sympatric, even if not typically present in exactly 259 
the same ecological niche. However, it would not be surprising if this proposed new 260 
species is responsible for the majority or even all of the CL cases in the Ho region of 261 
Ghana. The local name agbamekanu is also of interest, meaning "gift from somebody who 262 
has returned from a journey", and refers to the local belief that the disease has been 263 
brought in from neighbouring Togo, travel across the border between the Volta region and 264 
Togo being quite frequent. Whether this implied importation of CL is true remains 265 
uncertain, but other than young children, when the disease is found in older children and 266 
adults it is frequently the case that they are newcomers to the area. Thus the current 267 
pattern of infection more likely reflects an exposure of naïve individuals to what has 268 
become an established endemic focus in Ghana. Many aspects of this new focus require 269 
investigation, including the nature of the vector and presumed animal reservoir hosts, and 270 
a proper understanding of epidemiology, but these are important so that appropriate 271 
control measures can be considered to help those afflicted by agbamekanu. 272 
273 
Acknowledgements 274 
This work received support from Department of Microbiology, Parasitology Unit of the 275 
University of Ghana Medical School, The Wellcome Trust grant number 090678/Z/09/Z 276 
(GK-N,PAB) and the Leverhulme Trust/Royal Society Africa Award scheme (DB,PAB). The 277 
funders had no role in study design, data collection and analysis, decision to publish, or 278 
preparation of the manuscript. 279 
280 
References 281 
Bualert, L., Charungkiattikul, W., Thongsuksai, P., Mungthin, M., Siripattanapipong, S., 282 
Khositnithikul R, Naaglor T, Ravel C, El Baidouri F, Leelayoova S. 2012. 283 
Autochthonous disseminated dermal and visceral leishmaniasis in an AIDS patient, 284 
southern Thailand, caused by Leishmania siamensis. Am. J. Trop. Med. Hyg. 86, 285 
821-824. 286 
Croan, D.G., Morrison, D.A., Ellis, J.T., 1997. Evolution of the genus Leishmania revealed 287 
by comparison of DNA and RNA polymerase gene sequences. Mol. Biochem. 288 
Parasitol. 89, 149-159. 289 
Cupolillo, E., Medina-Acosta, E., Noyes, H., Momen, H., Grimaldi Jr., G., 2000. A Revised 290 
Classification for Leishmania and Endotrypanum. Parasitol. Today 16, 142-144. 291 
da Silva, E.S., Gontijo, C.M., Pacheco, R. da S., Brazil, R.P., 2004. Diagnosis of human 292 
visceral leishmaniasis by PCR using blood samples spotted on filter paper. Genet. 293 
Mol. Res. 3, 251-257.  294 
Degrave, W., Fernandes, O., Campbell, D., Bozza, M., Lopes, U., 1994. Use of molecular 295 
probes and PCR for detection and typing of Leishmania - a mini-review. Mem. Inst. 296 
Oswaldo Cruz 89, 463-469.  297 
Desbois, N., Pratlong, F., Quist, D., Dedet, J.P., 2014. Leishmania (Leishmania) 298 
martiniquensis n. sp. (Kinetoplastida: Trypanosomatidae), description of the 299 
parasite responsible for cutaneous leishmaniaisis in Martinique Island (French West 300 
Indies). Parasite 21, 12. 301 
Dougall, A., Shilton, C., Low Choy, J., Alexander, B., Walton, S., 2009. New reports of 302 
Australian cutaneous leishmaniasis in Northern Australian macropods. Epidemiol. 303 
Infect. 137, 1516-1520. 304 
Dougall, A.M., Alexander, B., Holt, D.C., Harris, T., Sultan, A.H., Bates, P.A., Rose, K., 305 
Walton, S.F., 2011. Evidence incriminating midges (Diptera: Ceratopogonidae) as 306 
potential vectors of Leishmania in Australia. Int. J. Parasitol. 41, 571-579. 307 
Faulde, M., Schrader, J., Heyl, G., Arnirih, M., Hoerauff, A., 2007. Zoonotic cutaneous 308 
leishmaniasis outbreak in Mazar-e Sharif, northern Afghanistan: An epidemiological 309 
evaluation. Int. J. Med. Microbiol. 298, 543-550. 310 
Fryauff, D.J., Hanafi, H.A., Klena, J.D., Hoel, D.F., Appawu, M., Rogers, W., Puplampu, 311 
N., Odoom, S., Kweku, M., Koram, K., Wilson, M.D., Raczniak, G., Boakye, D., 312 
2006. Short report: ITS-1 DNA sequence confirmation of Leishmania major as a 313 
cause of cutaneous leishmaniasis from an outbreak focus in the Ho district, 314 
southeastern Ghana. Am. J. Trop. Med. Hyg. 75, 502-504. 315 
Kweku, M.A., Odoom, S., Puplampu, N., Desewu, K., Kwakye-Nuako, G., Gyan, B., 316 
Raczniak, G., Kronmann, K.C., Koram, K., Botero, S., Boakye, D., Akuffo, H., 2011. 317 
An outbreak of suspected cutaneous leishmaniasis in Ghana: lessons learnt and 318 
preparation for future outbreaks. Glob. Health Action 4, 5527. 319 
Lainson, R., 1997. On Leishmania enriettii and other enigmatic Leishmania species of the 320 
neotropics. Mem. Inst. Oswaldo Cruz 92, 377–387. 321 
Liautaud, B., Vignier, N., Miossec, C., Plumelle, Y., Kone, M., Delta, D., Ravel, C., Cabié, 322 
A., Desbois, N., 2014. First case of visceral leishmaniasis caused by Leishmania 323 
martiniquensis. Am. J. Trop. Med. Hyg. 14-0205. 324 
Mendonca, M.G., de Brito, M.E.F., Rodrigues, E.H.G., Bandeira, V., Jardim, M.L., Abath, 325 
F.G., 2004. Persistence of Leishmania parasites in scars after clinical cure of 326 
American cutaneous leishmaniasis: Is there a sterile cure? J. Infect. 189, 1018-327 
1023. 328 
Meredith, S.E.O., Zijlstra, E.E., Schoone, G.J., Kroon, C.C.M., van Eys, G.J.J.M., 329 
Schaeffer, K.U., el-Hassan, A.M., Lawyer, P.G., 1993. Development and application 330 
of the polymerase chain reaction for the detection and identification of Leishmania 331 
parasites in clinical material. Arch. Inst. Pasteur Tunis 70, 419–431. 332 
Noyes, H., Pratlong, F., Chance, M., Ellis, J., Lanotte, G., Dedet, J.P., 2002. A previously 333 
unclassified trypanosomatid responsible for human cutaneous lesions in Martinique 334 
(French West Indies) is the most divergent member of the genus Leishmania ss. 335 
Parasitol. 124, 17-24. 336 
Nzelu, C.O., Kato, H., Puplampu, N., Desewu, K., Odoom, S., Wilson, M.D., Sakurai, T., 337 
Katakura, K., Boakye, D.A., 2014. First detection of Leishmania tropica DNA and 338 
Trypanosoma species in Sergentomyia sand flies (Diptera: Psychodidae) from an 339 
outbreak area of cutaneous leishmaniasis in Ghana. PLoS Neg. Trop. Dis. 8, 340 
e2630. 341 
Okwori, E.N.A., Nock, I.H., Galadima, M., Ibrahim, S., 2001. Prevalence of cutaneous 342 
leishmaniasis in parts of Kaduna State, Nigeria. J. Protozool. Res. 11, 32-46. 343 
Pothirat, T., Tantiworawit, A., Chaiwarith, R., Jariyapan, N., Wannasan. A., Siriyasatien, 344 
P., Supparatpinyo, K., Bates, M.D., Kwakye-Nuako, G., Bates, P.A., 2014. First 345 
isolation of Leishmania from northern Thailand: case report, identification as 346 
Leishmania martiniquensis and phylogenetic position within the Leishmania enriettii 347 
complex. PLoS Neg. Trop. Dis. 8, e3339. 348 
Ready, P.D., 2013. Biology of phlebotomine sand flies as vectors of disease agents. Annu. 349 
Rev. Entomol. 58, 227-250. 350 
Reithinger, R., Dujardin, J.C., Louzir, H., Pirmez, C., Alexander, B., Brooker, S., 2007. 351 
Cutaneous leishmaniasis. Lancet Infect. Dis. 7, 581-596. 352 
Rose, K., Curtis, J., Baldwin, T., Mathis, A., Kumar, B., Sakthianandeswaren, A., Spurck, 353 
T., Low Choy, J., Handman, E., 2004. Cutaneous leishmaniasis in red kangaroos: 354 
isolation and characterisation of the causative organisms. Int J Parasitol. 34, 655–355 
664. 356 
van Eys, G.J.J.M., Schoone, G.J., Kroon, N.C.M., Ebeling, S.B., 1992. Sequence analysis 357 
of small subunit ribosomal RNA genes and its use for detection and identification of 358 
Leishmania parasites. Mol. Biochem. Parasitol. 51, 133-142. 359 
Villinski, J.T., Klena, J.D., Abbassy, M., Hoel, D.F., Puplampu, N., Mechta, S., Boakye, D., 360 
Raczniak, G., 2007. Evidence for a new species of Leishmania associated with a 361 
focal disease outbreak in Ghana. Diagn. Microbiol. Infect. Dis. 60, 323-327. 362 
Yurchenko, V.Y., Lukes, J., Jirku, M., Zeledón, R., Maslov, D.A., 2006. Leptomonas 363 
costaricensis sp. n. (Kinetoplastea: Trypanosomatidae), a member of the novel 364 
phylogenetic group of insect trypanosomatids closely related to the genus 365 
Leishmania. Parasitol. 133, 537-546. 366 
367 
Figure Legends 368 
Figure 1. PCR diagnosis and RFLP. A. An example of diagnosis using kDNA minicircle 369 
primers. Lesions were cleaned with 70 % alcohol and scrapings stored on FTA cards 370 
(Whatman BioScience). Three 2 mm discs from each FTA sample were processed for 371 
PCR and the products examined by agarose gel electrophoresis. Numbers 59-65 above 372 
lanes refer to participant sample numbers; M1 is a 100 base pair ladder marker; N is a 373 
negative control; 357, 546, and FV1 are positive controls for L. tropica, L. aethiopica and L. 374 
major, respectively. B. An example of diagnosis using 18S rRNA primers.  Numbers 11-22 375 
refer to participant sample numbers; M1 is a 100 base pair ladder marker; N is a negative 376 
control; 357, 546, JPC, LV9 and FV1 are positive controls for L. tropica, L. aethiopica, L. 377 
infantum, L. donovani and L. major, respectively. C. Analysis of isolates by PCR-RFLP. 378 
DNA was purified from cultures of isolates GH5, GH10, GH11 and positive controls, 379 
amplified using primers AM1/AM2, and products digested with restriction enzyme MspI. M 380 
contains size markers; LV546, LV357 and FV1 are controls for L. aethiopica, L. tropica and 381 
L. major, respectively; N is a negative control. Further technical details are given in 382 
Supplementary Data S1, and further results in Supplementary Figure S1. 383 
384 
Figure 2. Appearance of lesions from confirmed cases of cutaneous leishmaniasis. 385 
Examples of typical active lesions are shown on several participants: A, on the arm; B, C, 386 
D, on the head; and E, on the back. In F is an example of the scar developing in a healing 387 
lesion. 388 
389 
Figure 3. Phylogenetic analysis of Ghanaian Leishmania. A. Maximum likelihood tree 390 
based on RPL23a intergenic sequences, with 22 species of Leishmania and 391 
Endotrypanum monterogeii, and using Crithidia fasciculata as an outgroup, based on 392 
alignment of 405-547 homologous nucleotide sequences. AM-2004 is an un-named 393 
species of Leishmania from Australia. The accession numbers for the sequences used are 394 
given in Table S1 and the various subgenera and other groups are as indicated. Bootstrap 395 
values from 1000 replicates are given at the nodes. B. Maximum likelihood tree based on 396 
RNA Polymerase II large subunit gene sequences, with 22 species of Leishmania and 397 
Endotrypanum monterogeii, using Crithidia fasciculata as an outgroup, based on alignment 398 
of 1191-1200 homologous nucleotide sequences. Accession numbers are given in Table 399 
S1. Further technical details are given in Supplementary Data S1. 400 
401 
402 
Supplementary Information Legends 403 
404 
Figure S1. Further examples of PCR diagnosis. A. Four panels showing PCR results 405 
from diagnosis using kDNA minicircle primers. Numbers above lanes refer to participant 406 
sample numbers; M1 is a 100 base pair ladder marker; N is a negative control; 357, 546, 407 
and FV1 are positive controls for L. tropica, L. aethiopica and L. major, respectively. B. 408 
Two panels showing PCR results from diagnosis using 18S rRNA primers.  Numbers 409 
above lanes refer to participant sample numbers; M1 is a 100 base pair ladder marker; N 410 
is a negative control; 357, 546, JPC, LV9 and FV1 are positive controls for L. tropica, L. 411 
aethiopica, L. infantum, L. donovani and L. major, respectively. 412 
413 
Figure S2. Multiple sequence alignment of ITS1 sequences. The sequences derived 414 
from three independent CL cultures (GH5, GH10 and GH11; accession numbers 415 
KP006688-KP006690) are aligned with the sequence from Villinski et al. [17] (TAVE; 416 
EF524071), previously attributed to a new species of Leishmania. Identical residues are 417 
indicated by asterisks and the two variable residues are shaded. 418 
419 
Figure S3. Participant recruitment. Villages were visited through the year, the number of 420 
participants recruited into the study during different months is shown. 421 
422 
Table S1. Accession numbers of sequences used for phylogenetic analysis. 
 
Species WHO Code Accession number 
for RPL23a IGS 

















L. adleri RLIZ/KE/XXXX/LV30 KP025941
a
 RLIZ/KE/XXXX/LV30 AF009153 
L. amazonensis MHOM/BR/1997/M2269 FR693777 MHOM/BR/1973/LV78 AF009154 
Leishmania new species 
from Australia 
MMAC/AU/2004/AM-2004;Roo1 FR693774 MMAC/AU/2004/AM-2004;Roo1 HM775497 
L. braziliensis MHOM/BR/83/LTB300 FR693776 MHOM/VE/XXXX/LBV AF009155 
L. colombiensis IHAR/CO/1996/CL500;LEM2334 KP025942
a
 IHAR/CO/1996/CL500;LEM2334 KM820662 
L. donovani MHOM/ET/67/HU3;L82;LV9 FR693771 MHOM/IN/1980/DD8 AF009157 
L. enriettii MCAV/BR/1945/LV90 FR693773 MCAV/BR/1945/LV90 AF151727 
L. equatorensis MCHO/EC/1982/Lsp1;L888 KP025943
a
 MCHO/EC/1982/Lsp1;L888 DQ383655 
L. gerbilli MRHO/CN/1960/Gerbilli;LON-25 FR693785 MRHO/CN/1960/Gerbilli;LON-25 AJ304947 
L. guyanensis MHOM/BR/75/M4147 FR693784 MHOM/SR/1987/TRUUSI AJ304949 
L. gymnodactyli RGEC/SU/XXXX/LV247 FR693781 RGEC/SU/XXXX/LV247 AF009159 
L. hertigi MCOE/PA/1965/C-8;LV42 FR693775 MCOE/PA/1965/C-8;LV42 AF009161 
L. hoogstraali RLIZ/SD/XXXX/LV31 FR693782 RLIZ/SD/XXXX/LV31 AF009162 
L. infantum MCAN/ES/1998/LEM-935;JPCM5 FR796438 MCAN/ES/1998/LEM-935;JPCM5 XM_001467548 
L. major MHOM/IL/1980/Friedlin;FV1 FR796402 MHOM/IL/1980/Friedlin;FV1 XM_001685196 
L. martiniquensis MHOM/MQ/1992/MAR1; LEM2494 KP025945
a
 MHOM/MQ/1992/MAR1; LEM2494 KM820663 
L. mexicana MNYC/BZ/1962/M379 FR693769 MNYC/BZ/1962/M379 AF009164 
L. panamensis MHOM/PA/XX/53A;LV145 FR693783 MHOM/PA/XXXX/CIDEP004 AF009165 
“L. siamensis” MHOM/TH/2010/PCM2;Trang KP025944
a
 MHOM/TH/2010/PCM2;Trang KM820664 
L. tarentolae RTAR/SE/67/G10/LV108 FR693780 RTAR/DZ/1939/LV414 AF009166 
L. tropica MHOM/IR/60/LV357 FR693778 MHOM/SU/1958/Strain-OD AF009167 
L. turanica MRHO/SU/83/MARZ-051 FR693786 IRAI/TR/1991/M87 AJ304946 
Endotrypanum monterogeii MCHO/CR/1962/LV88;A9 FR693788 MCHO/CR/1962/LV88;A9 AF009158 









aThose that have been generated as part of this study. bTriTrypDB identifier (http://tritrypdb.org/tritrypdb/), Stephen M. Beverley and The 
Genome Institute, Washington University School of Medicine. 
 
Supplementary Table S1
Table S2. Age group and gender distribution in confirmed CL cases. Diagnosis 
was confirmed by PCR from dermal scrapings (38 participants) or by culture and 
DNA sequencing (3 participants). 
Age Group Sex Total 
Male Female 
0-10 14 10 24 
11-20 1 1 2 
21-30 0 7 7 
31-40 0 2 2 
41-50 1 0 1 
≥51 2 3 5 
Total 18 23 41 
Supplementary Table S2
Table S3. Numbers of lesions on different regions of the body in confirmed CL 
cases. The majority of cases presented with single lesions (33/41) but 8 individuals had 
multiple lesions. 





















































































































































TAVE ATTACACCAAAAAAAAACATACAATCAAAACACGGGGAGGTGTATCTCTCTTTTTGTCAG 60 
GH5 ATTACACCAAAAAAAAACATACAATCAAAACACGGGGAGGTGTATCTCTCTTTTTGTCAG 60 
GH10 ATTACACCAAAAAAAAACATACAATCAAAACACGGGGAGGTGTATCTCTCTTTTTGTCAG 60 
GH11 ATTACACCAAAAAAAAACATACAATCAAAACACGGGGAGGTGTATCTCTCTTTTTGTCAG 60 
************************************************************ 
TAVE ATAACGCCTTTCCCACATACACACACAACAATATATATGTATATATGTATTGTTATACTC 120 
GH5 ATAACGCCTTTCCCACATACACACACAACAATATATATGTATATATGTATTGTTATACTC 120 
GH10 ATAACGCCTTTCCCACATACACACACAACAATATATATGTATATATGTATTGTTATACTC 120 
GH11 ATAACGCCTTTCCCACATACACACACAACAATATATATGTATATATGTATTGTTATACTC 120 
************************************************************ 
TAVE AATTATACAGTAAACAGAAAAACAAAGGCCGGTCGACATATACACACCGCGCGTATATAT 180 
GH5 AATTATACAGTAAACAGAAAAACAAAGGCCGGTCGACATATACACACCGCGCGTATATAT 180 
GH10 AATTATACAGTAAACAGAAAAACAAAGGCCGGTCGACATATACACACCGCGCGTATATAT 180 
GH11 AATTATACAGTAAACAGAAAAACAAAGGCCGGTCGACATATACACACCGCGCGTATATAT 180 
************************************************************ 
TAVE ATATATACAACGAAAATGTCCCTTCTTACGGGGGCTTTTCTGGCGGTGTGCTGTGGATAA 240 
GH5 ATATATACAACGAAAATGTCCCTTCTTACGGGGGCTTTTCTGGGGGTGTGTTGTGGATAA 240 
GH10 ATATATACAACGAAAATGTCCCTTCTTACGGGGGCTTTTCTGGCGGTGTGTTGTGGATAA 240 
GH11 ATATATACAACGAAAATGTCCCTTCTTACGGGGGCTTTTCTGGCGGTGTGTTGTGGATAA 240 
******************************************* ****** ********* 
TAVE CGGCTCACAT 250 
GH5 CGGCTCACAT 250 
GH10 CGGCTCACAT 250 
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Supplementary Figure 3
Supplementary Data S1 
Sample collection 
Skin scrapings were collected from the site of an active lesion using a single-
use sterile scalpel. The surfaces and about 30 mm around the diameter of the 
lesions were cleaned with 70 % alcohol. The scrapings obtained from the borders 
and the centre of the ulcerated lesions were transferred into 150 µl of phosphate 
buffered saline (PBS) contained in 1.5 ml microfuge tubes. The PBS and their 
contents were then spotted onto FTA cards (Whatman BioScience WB12 0205) and 
air-dried. Samples were stored in closed plastic bags and kept under dry conditions 
at room temperature to preserve DNA for later PCR analysis. Alternatively, lesions 
were sterilized with 70 % alcohol, anaesthetized with 1 % lidocaine and sampled by 
needle aspiration. Aspirates were placed into bijou tubes containing 2 ml of Hank’s 
balanced salt solution (Life Technologies 14170-112) and 25 µg/ml gentamicin 
sulphate, and stored on ice until processing in the laboratory. Any bleeding was 
controlled and a sterile dressing applied. All patients received treatment against 
secondary infections with topical antibiotics and antifungal creams. 
PCR using FTA discs 
Samples were prepared according to the manufacturer’s instructions.  At least 
three 2 mm discs from different sites on the same sample spot of the FTA card were 
excised using a carbon steel surgical blade and placed in PCR amplification tube.  A 
single blade was used for each sample to prevent cross contamination between 
samples. The excised discs were then suspended in 200 µl of FTA purification 
reagent (Whatman Bioscience WB12 0204) in the PCR tube and incubated for 5 
Supplementary Data S1
minutes at room temperature.  The FTA Purification Reagent was then removed and 
discarded. This washing step was repeated for a total of 3 washes with FTA 
purification reagent. After the third wash, the discs were re-suspended in 200 µl of 
TE buffer (10 mm Tris-HCl, 0.1 mM EDTA, pH 8.0) and incubated for 5 minutes at 
room temperature, after which the TE buffer was removed and discarded. The 
washing procedure with TE buffer was repeated three times. Finally, the discs were 
allowed to dry at room temperature for 1 hour. PCR reagents were then added 
directly to the discs in the tube. Primers Mincr2 (5′ GGG GAG GGG CGT TCT GCG 
AA 3′) and Mincr3 (5′ CGC CCC CTA TTT TAC ACA ACC CC 3′) were used in an 
optimized PCR reaction mixture with conditions as follows: 25 μl volumes were 
prepared using 2 x Reddy MixTM PCR Master Mix (ABgene AB-0575/DC/LD) (1.5 mM 
MgCl2, 1.25 units Taq DNA polymerase, 75 mm Tris-HCl (pH 8.8 at 25 ºC), 20 mM 
(NH4)2 SO4, 0.01 % (v/v) Tween 20, 0.2 mM each of dATP, dCTP, dGTP, dTTP, and 
Precipitant and red dye for electrophoresis), 100 pmol of each primer and 2 mm 
incised discs of the FTA card. Initial denaturation was at 94 ºC for 5 minutes, 
followed by 35 cycles of 94 ºC for 30 seconds, annealing at 60 ºC for 30 seconds, 
extension at 72 ºC for 1 minute 30 seconds, and a final extension at 72 ºC for 3 
minutes. Primers R221 (5′ GGT TCC TTT CCT GAT TTA CG 3′) and R332 (5′ GGC 
CGG TAA AGG CCG AAT AG 3′) were used in an optimized PCR reaction mixture 
on FTA discs with conditions as above, except that a 1.1 x master mix with 2.5 mM 
MgCl2 was used (Abgene AB-0619/LD) and a 63 ºC annealing temperature. 
PCR on cultured parasites 
DNA extraction from parasites was performed using a QIAamp DNA Mini Kit 
(Qiagen), following the manufacturer’s instructions. Amplification of the ITS1 
sequence was performed using primers L5.8S (TGA TAC CAC TTA TCG CAC TT) 
and LITSR (CTG GAT CAT TTT CCG ATG). Amplification of the RPS7 intergenic 
sequence was performed using primer pairs AM1 (CGC GTG TCG TTC GGC TTT 
ATG TG) and AM2 (CTT ACG GAG CTT GCT GAG GTG AGG), followed by 
digestion with restriction enzyme MspI. Amplification of the RPL23a intergenic 
sequence was performed using primers BN1 (GAA GGT CAA CAC CCT GAT CC) 
and BN2 (CTT CTT GGC GGT CTT CTG AG). Amplification of RNA Polymerase II 
was performed with several primer pairs: RPOF1 (GAC ACA GCC GTC AAG AC) 
and RP0R1 (GCA GCC GCA CAA TGC GCT); PolIIN5 (GCA CTT CAT GTT GGA 
CGA CT) and PolIIN6 (GTA CTT GGT GCG GAT CTC CT); PolIIN7 (AGG AGT ACA 
GGC TGA ACG AC) and PolIIN8 (TGT CGT CCA CTT GCC GGA). Amplification 
was performed with proof-reading DNA polymerase (Qiagen HotStar HiFidelity 
Polymerase). 
Agarose gel electrophoresis 
PCR products were loaded onto 8 cm 1.5 % - 2 % agarose gels containing 5 
ng/µl ethidium bromide and Tris-acetate (TAE) buffer and electrophoresed for 45 
minutes to 1 hour at 75 – 100 V. DNA bands were examined under ultraviolet trans-
illumination and their size determined by comparison with markers. Alongside test 
samples, positive controls were run including products generated from L. donovani 
(MHOM/ET/67/HU3; LV9); L. infantum (MCAN/ES/98/LEM-935; JPC; M5);   L. 
tropica (MHOM/IR/60/LV357); L. major (MHOM/IL/80/Friedlin; FV1); and L. 
aethiopica (MHOM/ET/72/LRC-L147/546). 
DNA sequencing and phylogenetic analysis 
Products were directly sequenced using commercial services. Results were 
checked for quality using Chromas Lite 2.1.1 (http://technelysium.com.au/). Initial 
alignments and analyses were performed using Clustal W2 
(http://www.ebi.ac.uk/Tools/msa/clustalw2/). For phylogenetic analysis, alignment 
and tree building programmes in MEGA version 6 were used 
(http://www.megasoftware.net/). Testing of alternative models was performed, for 
RPL23a sequences the Hasegawa-Kishino-Yano model and for RNA polymerase the 
Tamura-Nei model were the best fitting models of sequence evolution, respectively, 
and these were used for tree construction using the maximum likelihood method. 
Bootstrapping was performed on all trees with 1000 replicates. 
